Viewing nowRivatin Tablet 10 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Pamgen Science Co., Ltd.

MFDS item code 201208754 · Approved 2012.11.28 · Insurance code 670103330
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication helps reduce the risk of cardiovascular disease. In particular, it is used to reduce the risk of myocardial infarction or stroke, complications after vascular surgery, and angina in adult patients aged 55 or older who have risk factors such as smoking, hypertension, low HDL cholesterol levels, or a family history. It is also helpful in reducing the risk of myocardial infarction and stroke in patients with type 2 diabetes with conditions such as retinopathy, albuminuria, smoking, or hypertension. In patients with coronary heart disease, it mitigates the risk of myocardial infarction, stroke, vascular surgery, hospitalization due to congestive heart failure, and angina. Additionally, it reduces cholesterol and triglyceride levels in patients with primary and mixed hyperlipidemia, and increases good cholesterol (HDL) levels. It is effective for some patients with hypercholesterolemia or dyslipidemia that are difficult to manage with diet, as well as children aged 10-17 years with heterozygous familial hypercholesterolemia. Therefore, this drug is used to effectively improve cardiovascular disease and hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is for patients who require an LDL cholesterol reduction of 45 % or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on administering doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This drug may cause muscle-related adverse effects, so if you experience muscle pain or weakness, you should stop taking it immediately and consult your doctor. Special attention is required as there is a risk of kidney function problems due to severe muscle pain or damage. Patients with liver function issues or elevated liver enzyme levels should not take this medication, and should inform their doctor immediately if symptoms of liver dysfunction occur. Women who are pregnant or may become pregnant, as well as nursing women, should not take this medication. This drug is not administered to children, especially those under 10 years of age. Alcoholics or patients with a history of liver disease should use this medication cautiously, and elderly patients should also be careful due to the higher risk of muscle-related side effects. This medication can interact with other drugs, so it is essential to consult with a doctor or pharmacist when taking it with specific antibiotics, antifungals, antivirals, or immunosuppressants. Consuming grapefruit juice may increase the blood concentration of this medication, so excessive intake should be avoided. If symptoms such as muscle pain, weakness, fatigue, or fever occur during treatment, you should inform your doctor immediately and undergo testing. It is safe to take this medication while regularly checking liver function and muscle status through blood tests. Keep this medication out of reach of children and store it in the original container to maintain its quality. There is no specific antidote for overdose, so seek immediate medical attention for appropriate treatment.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a sealed container. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius. By doing so, the effectiveness of the medication can be preserved for a longer period.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Pamgen Science Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.